Tuesday, 02 January 2024 12:17 GMT

Syensqo Exercises The Make-Whole Option To Early Redeem €500 Million Senior Bonds


(MENAFN- GlobeNewsWire - Nasdaq)
Press release

Regulated information

Syensqo exercises the make-whole option to early redeem €500 million senior Bonds

Brussels, February 27, 2026 - 8:30 CET


Syensqo SA (the“Issuer”) today announced its decision to exercise its make-whole redemption option to redeem its Euro 500,000,000 2.750 per cent. Fixed Rate Bonds due December 2, 2027 (ISIN: BE6282460615), following notification to the Agent and the Calculation Agent, the National Bank of Belgium, and the Luxembourg Stock Exchange, where the bonds are listed.

The redemption will occur on March 31, 2026. The Issuer will redeem all outstanding Bonds at the make-whole redemption amount plus accrued interest up to the redemption date. The redemption amount will be determined and calculated by the Calculation Agent and notified thereafter to the Bondholders as per the Conditions of the Bonds.

“By exercising this make-whole option, we are efficiently allocating available cash resources, deleveraging and further strengthening our strong investment-grade profile.” said Christopher Davis, Chief Financial Officer of Syensqo.

Link to the notice published on the Luxembourg Stock Exchange.

Full press release available here.

About Syensqo

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.

Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and healthcare applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Learn more at .

Contacts

Media Relations
...
Perrine Marchal
+32 478 32 62 72
Laetitia Schreiber
+32 487 74 38 07
Investors & Analysts
...
Sherief Bakr
+44 7920 575 989
Robbin Moore-Randolph
+1 470 493 2433
Loïc Flament
+32 478 69 74 20
Eva Behaeghe
+32 474 49 23 50

Safe harbor
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

Useful links

  • Earnings materials
  • Strategy
  • Share information
  • Credit information
  • Separation documents
  • Webcasts, podcasts and presentations
  • Annual Integrated Report
  • Subscribe to our distribution list

Attachment

  • 260227 - PR - Make whole Bonds 2027

MENAFN27022026004107003653ID1110797528



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search